These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 11332376)

  • 1. [Prescription of central nervous system stimulants].
    Asheim H; Nilsen KB; Stordahl H; Johansen K
    Tidsskr Nor Laegeforen; 2001 Mar; 121(8):908-10. PubMed ID: 11332376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prescribing of stimulants for ADHD in Nordland County].
    Asheim H; Nilsen KB; Johansen K; Furu K
    Tidsskr Nor Laegeforen; 2007 Sep; 127(18):2360-2. PubMed ID: 17895938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperactivity and prescription of Ritalin in the canton of Vaud (Switzerland), 2002].
    Huissoud T; Jeannin A; Dubois-Arber F
    Rev Epidemiol Sante Publique; 2007 Oct; 55(5):357-63. PubMed ID: 17889474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is Ritalin prescribed insufficiently to hyperactive children in Nordland?].
    Neraal T
    Tidsskr Nor Laegeforen; 2001 May; 121(14):1735-6. PubMed ID: 11446022
    [No Abstract]   [Full Text] [Related]  

  • 5. Prescriptions for ADHD medication, 2004-08.
    Lillemoen PK; Kjosavik SR; Hunskår S; Ruths S
    Tidsskr Nor Laegeforen; 2012 Sep; 132(16):1856-60. PubMed ID: 22986969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
    Marcus SC; Wan GJ; Kemner JE; Olfson M
    Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication.
    Schertz M; Adesman AR; Alfieri NE; Bienkowski RS
    Pediatrics; 1996 Oct; 98(4 Pt 1):763-9. PubMed ID: 8885958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of methylphenidate prescription among school-aged children in a Swiss population: increase in the number of prescriptions in the Swiss Canton of Vaud, from 2002 to 2005, and changes in patient demographics.
    Gumy C; Huissoud T; Dubois-Arber F
    J Atten Disord; 2010 Nov; 14(3):267-72. PubMed ID: 20484708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increasing trend in prescription of methylphenidate in general practices in the north-east of The Netherlands, 1998-2003].
    Donker GA; Groenhof F; van der Veen WJ
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1742-7. PubMed ID: 16114292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate patterns among Medicaid youths.
    Zito JM; Safer DJ; dosReis S; Magder LS; Riddle MA
    Psychopharmacol Bull; 1997; 33(1):143-7. PubMed ID: 9133766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders].
    Aanonsen NO
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AD(H)D.
    Harrison C; Charles J; Britt H
    Aust Fam Physician; 2008 Jun; 37(6):393. PubMed ID: 18523688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical treatment of children and youths with attention-deficit/hyperactivity disorder (ADHD): a Norwegian Prescription Registry Based Study.
    Norum J; Olsen AI; Nohr FI; Heyd A; Totth A
    Glob J Health Sci; 2014 Apr; 6(4):155-62. PubMed ID: 24999151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of methylphenidate among children in Iceland 1989-2006].
    Zoëga H; Baldursson G; Halldórsson M
    Laeknabladid; 2007 Dec; 93(12):825-32. PubMed ID: 18057472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.
    Janols LO; Liliemark J; Klintberg K; von Knorring AL
    Nord J Psychiatry; 2009 Nov; 63(6):508-16. PubMed ID: 19958258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands.
    Hodgkins P; Sasané R; Meijer WM
    Clin Ther; 2011 Feb; 33(2):188-203. PubMed ID: 21497704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early discontinuation of attention-deficit/hyperactivity disorder drug treatment: a Danish nationwide drug utilization study.
    Pottegård A; Bjerregaard BK; Kortegaard LS; Zoëga H
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):349-53. PubMed ID: 25220739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate use for attention deficit hyperactivity disorder in northern Israel--a controversial issue.
    Fogelman Y; Kahan E
    Isr Med Assoc J; 2001 Dec; 3(12):925-7. PubMed ID: 11794916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.